WESTON, FL , DNAPrint Genomics, Inc. (OTCBB: DNAG), Paradigm Medical Industries, Inc. (OTCBB: PMED), Apple (NASDAQ: AAPL).

Visit TheSUBWAY's Small Cap Investor Forum Here: http://www.thesubway.com/small-cap-forum/ to discuss our daily stock picks throughout the trading day!

China America Holdings, Inc. (OTCBB: CAAH) just announced the company's business outlook for 2008. Throughout 2007, management began transitioning the company by diversifying its operations through strategic acquisitions in China in an effort to increase revenue and move the company toward a profitable future. The company was able to make two key acquisitions in China in 2007 and also changed its name to China America Holdings, Inc. in order to more accurately reflect its new business objective.

Management intends to continue its rapid growth over the next several years through a combination of the expansion of its current operations as well as our continued focus on making accretive acquisitions. Management now anticipates that 2008 will be a record year for the company both in revenue and more importantly in achieving its first profitable year of operations. Based on the company's preliminary review of our business outlook for 2008 management sees revenue for China America Holdings, Inc. exceeding $50 million and anticipates net income will exceed $1.2 million.

Other stocks highlighted include DNAPrint Genomics, Inc. (OTCBB: DNAG): Hot Stocks List, up 20% on 42 million shares, Paradigm Medical Industries, Inc. (OTCBB: PMED): Hot Stocks List, up 1% on 37 million shares, Apple (NASDAQ: AAPL): Hot Stocks List, down 1% on 36 million shares.

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated one hundred thousand shares for CAAH. CRGP was compensated by StockPromoters.com Consultants LLC who received one hundred thousand dollars and one million one hundred thousand shares of CAAH for their services. The owner of StockPromoters.com Consultants LLC is also the owner of Capital Research Group Inc. and TheSUBWAY.com Inc. CRGP intends to sell its shares. CRGP has sold approximately zero CAAH shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site operate under a license from Capital Research Group, Inc., TheSUBWAY.com Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's Licensors, affiliates, officers, directors and employees own shares and intend to buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact: Joe Farrar President CRG Partners, Inc. 973-332-1366 www.TheSUBWAY.com

DNAPrint Genomics (CE) (USOTC:DNAG)
Historical Stock Chart
Von Mär 2025 bis Apr 2025 Click Here for more DNAPrint Genomics (CE) Charts.
DNAPrint Genomics (CE) (USOTC:DNAG)
Historical Stock Chart
Von Apr 2024 bis Apr 2025 Click Here for more DNAPrint Genomics (CE) Charts.